Celldex Therapeutics (CLDX) EBT Margin (2010 - 2026)
Celldex Therapeutics' EBT Margin came in at -334104.55% for Q2 2026, down 326351.12 percentage points from -7753.42% a year earlier but up 190462.12 percentage points from the prior quarter.
Celldex Therapeutics (CLDX) EBT Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported EBT Margin of -190220.89%, down 186774.00 percentage points year-over-year; for FY2025, it was -16748.03%, down 14499.27 percentage points from FY2024.
- EBT Margin carries a five-year change of -15926.42 percentage points (FY2020 to FY2025).
- Going back by year, EBT Margin was -2248.76% in FY2024 (-194.00 pp), -2054.76% in FY2023 (+2710.83 pp), -4765.59% in FY2022 (-3244.67 pp) and -1520.92% in FY2021 (-699.31 pp).
- The five-year range for quarterly EBT Margin is -524566.67% (Q1 2026) to -1048.32% (Q4 2023).
- Year-over-year, EBT Margin has declined for three consecutive quarters, with an average year-over-year change of -128737.05 percentage points over the last seven quarters.
- The fastest year-over-year change in EBT Margin over five years came in Q1 2025 (a gain of 13290.34 percentage points), and the weakest in Q1 2026 (a drop of 516826.24 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | -334,104.55% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -334,104.55% |
| Mar 31, 2026 | -524,566.67% |
| Dec 31, 2025 | -67,204.13% |
| Jun 30, 2025 | -7,753.42% |
| Mar 31, 2025 | -7,740.43% |
| Dec 31, 2024 | -4,007.83% |
| Sep 30, 2024 | -1,319.99% |
| Jun 30, 2024 | -1,434.83% |
| Mar 31, 2024 | -21,030.77% |
| Dec 31, 2023 | -1,048.32% |
| Sep 30, 2023 | -2,522.08% |
| Jun 30, 2023 | -11,381.34% |
| Mar 31, 2023 | -3,036.30% |
| Dec 31, 2022 | -1,642.10% |
| Sep 30, 2022 | -6,580.84% |
| Jun 30, 2022 | -22,088.34% |
| Mar 31, 2022 | -13,247.13% |
| Dec 31, 2021 | -6,032.34% |
| Sep 30, 2021 | -13,515.69% |
| Jun 30, 2021 | -384.28% |
Celldex Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();